Greg
@GregNowakowski
Followers
727
Following
295
Media
15
Statuses
72
oncology hematology lymphoma ASCO ASH
Minnesota, USA
Joined April 2013
Right in time! Nice paper of 🇮🇹🇨🇿🇨🇭🇺🇸centers out! Primary Extranodal Follicular Lymphoma: A Retrospective Survey of the International Extranodal Lymphoma Study Group (IELSG) @StefanoLuminari @GregNowakowski @MarekTrnenyDr
0
2
10
CONGRESS | #18ICML | PRESENTATION Patrick B Johnston, @MayoClinic highlights results from the phase II DAILY II US trial of zamtocabtagene autoleucel in patients with R/R CNSL (N = 16). Zamto-cel was well tolerated in patients with R/R CNSL, with encouraging efficacy (ORR,
1
10
25
Pola-R-CHP the new SOC for ALL DLBCL? @SoniSmithMD YES vs. @GregNowakowski NO Pola-R-CHP, RCHOP Some need Pola-R-CHP Some don't have access to Pola Some will be fine with RCHOP @icmlugano #18ICML #lymsm
5
3
9
Dr Ansell discussing plenary abstract ICML Lugano on predicting response to CART by microenvironment signature @MayoCancerCare
3
4
34
Late-breaking abstract featured at #ASCO25: @MayoClinic researchers found the addition of #immunotherapy to chemotherapy can reduce the recurrence and spread of #ColonCancer in patients with deficient DNA mismatch repair (dMMR). Learn more: https://t.co/0wfcqI8G2f
@FASinicropeMD
1
10
23
Thank you @MayoClinic for recognizing Dr. Lee Greenberger, our SVP & Chief Scientific Officer of 11 years, for his service in the #BloodCancer space and collaboration in IMPACT grants last night. #ASH24 🔬🩸
0
6
16
Honored to be on the ballot for the Designated Community Oncology seat. ASCO has done a remarkable job of selecting a lineup of brilliant candidates. I personally have SO MUCH respect for each one of them! Your voice counts, please vote. https://t.co/TrPpQjHe2H
@ASCO @ASCOPres
3
9
28
We are seeking a lymphoma investigator to join our Lymphoid Malignancies Disease Group at @MayoClinic in Rochester, MN. Join @GregNowakowski, Steve Ansell, @WitzigLab and may other talented individuals to advance lymphoma care and research. https://t.co/tlKACrH7sR
1
7
30
I’m honored to be on the ballot for the ASCO Board of Directors with all the other amazing candidates. Learn more and 🗳️ ⬇️
Voting in the ASCO Election is open now until December 3! Meet the candidates for the Board of Directors – Undesignated Member seat. Learn more about each candidate, determine your voting eligibility, and make your voice heard at https://t.co/dvxay4gojm
1
10
46
Great discussion on the present and future of oncology drug development with Dr. Rick Pazdur - Distinguished Lecturer at MCCCC. @realrickpazdur @MayoCancerCare @US_FDA
1
3
15
Dinner with @GregNowakowski and my excellent junior colleagues after great Gregg’ s talk and discussion in @UniKarlova Gen Hospital
2
2
13
100 years of Hematology @MayoClinic Rochester, MN Hematology Division Faculty @MayoCancerCare
6
19
160
Grzegorz S. Nowakowski, MD, discusses the accelerated approval of epcoritamab in follicular lymphoma, touching on key trial data and remaining unmet needs. @GregNowakowski @MayoClinic #lymsm #oncology #MedTwitter
onclive.com
Grzegorz S. Nowakowski, MD, discusses the accelerated approval of epcoritamab in follicular lymphoma, touching on key trial data and remaining unmet needs.
0
3
4
Lots of great connections happening at #ASCO24 (mainly thanks to this pin). Stop by and say 👋 to Dr. @GregNowakowski and our experts at @MayoClinic booth no. 27104!
0
9
30
PhD thesis today @ComeBommier discussing about MZL, surrogacy, endpoints. Strong collaboration with Mayo Clinic, Congratulations !
5
4
40
An ASCO task force paper published today in @JournalCancer details 3 calls-to-action for the oncology research and care communities that could expand access to clinical trials and enable patients to participate closer to home. Learn more: https://t.co/LRt7blr772
#OncTwitter
1
15
21
Great to join @FDAOncology, @AACR, @AmstatNews for today's workshop on Overall Survival in cancer clinical trials Nice introduction from @FDAOncology's Dr Gormley on different endpoint considerations & nuances of interpreting OS #AACRSciencePolicy @tmprowell
2
11
48
Join us for the ASH|FDA Collaboration: A Workshop on Regulatory Science in Hematology to gain a deeper understanding of the @US_FDA’s role in #hematology 🩸 Learn about product development, clinical trial design, & more! Apply now: https://t.co/tL38a4AfPs
0
2
11
Looking forward joining discussion with great faculty colleagues at the PER symposium on experts addressing burning questions in DLBCL at ASCO in Chicago on June 2! Sign up today! https://t.co/kM5tda342t
#HemOnc #gotoPER
1
1
10